Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Evaluation of a Novel Technique for the Discovery of New, Tumor-specific Targets for the Deployment of Innovative Immunotherapeutics Against Cancer.
NCT06629233
- Conditions
- Estrogen Receptor Positive Breast Cancer
- Locations
-
- AZ Maria Middelares Ghent, East-Flanders, Belgium
- University Hospital Ghent Ghent, East-Flanders, Belgium
Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy
NCT06623903
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +6 more
- Locations
-
- Department of Oncology, Aarhus University Hosptial Aarhus N, Central Jutland, Denmark
NCT00066690
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +11 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
NCT02668666
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +8 more
- Locations
-
- University of Illinois Cancer Center Chicago, Illinois, United States
- Michigan State University Lansing, Michigan, United States
- University of Minnesota Minneapolis, Minnesota, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT02216786
- Conditions
- Estrogen Receptor Positive Breast Cancer
- Locations
-
- ICO Paul Papin Angers, France
- Institut Sainte Catherine Avignon, France
- Antoine Lacassagne Centre De Lutte Contre Le Cancer De Nice Nice, France
- Hospital Center Private Saint-Grégoire Saint-Grégoire, France
NCT02820961
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Sarah Cannon Research Institute HealthONE Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
NCT02988986
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +4 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Houston Methodist Hospital Willowbrook Houston, Texas, United States
- Houston Methodist Hospital Sugar Land Sugar Land, Texas, United States
NCT01219699
- Conditions
- Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer
- Locations
-
- UCSF Medical Center San Francisco, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(4) Nashville, Tennessee, United States
- Vanderbilt Univeristy SC Nashville, Tennessee, United States
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
NCT02947685
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +5 more
- Locations
-
- UCSF San Francisco, California, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Baycare Healthcare (Morton Plant Mease) Clearwater, Florida, United States
- Memorial Healthcare System Hollywood, Florida, United States
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
NCT01984138
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Houston Methodist Cancer Center Houston, Texas, United States
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
NCT01992952
- Conditions
- Estrogen Receptor Positive Breast Cancer
- Locations
-
- Velindre NHS Trust Cardiff, United Kingdom
- Christie Hospital Manchester, Greater Manchester, United Kingdom
- Ysbyty Gwynedd Bangor, United Kingdom
- Clatterbridge Cancer Centre Bebington, United Kingdom
FDG PET/CT in Breast Cancer Bone Mets
NCT01996046
- Conditions
- Bone Metastases, Estrogen Receptor Positive Breast Cancer
- Locations
-
- University of Pennsylvania Hospital Philadelphia, Pennsylvania, United States
A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers
NCT02238808
- Conditions
- Estrogen Receptor Positive Breast Cancer
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada